UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement
Sales, net	$ 10,717	$ 10,032	$ 31,035	$ 30,408
Cost of goods sold	4,521	4,083	12,440	12,129
Gross profit	6,196	5,949	18,595	18,279
Operating expense:
Selling, general and administrative	2,079	2,158	6,336	6,641
Research and development	115	126	352	369
Total operating expense	2,194	2,284	6,688	7,010
Operating income	4,002	3,665	11,907	11,269
Other income (expense)	(107)	(88)	(300)	(278)
Income before provision for income taxes	3,895	3,577	11,607	10,991
Provision for income taxes	1,073	1,006	3,229	3,053
Net income	2,822	2,571	8,378	7,938
Earnings per common share (basic)	$ 0.75	$ 0.69	$ 2.24	$ 2.13
Earnings per common share (diluted)	$ 0.75	$ 0.68	$ 2.22	$ 2.11
Shares outstanding (basic)	3,741	3,735	3,747	3,724
Shares outstanding (diluted)	3,764	3,781	3,774	3,771
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	(2,569)	2,573	(1,459)	76
Unrealized gain (loss) on investments net of taxes of $2, $0, $0 and $4	3	0	0	6
Total comprehensive income	$ 256	$ 5,144	$ 6,919	$ 8,020